Allergan acquires NMDA depression drug from Aptinyx collaboration

Allergan has acquired an investigational NMDA receptor modulator discovered by Aptinyx, exercising its option under an ongoing collaboration, and plans to pair it with its rapastinel depression therap…
Read the full story: FierceBiotech: Biotech